Key facts
- This page summarizes Brightstar Associates LLC's Form 4 filing for Deciphera Pharmaceuticals, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Apr 2024, 16:30.
Brightstar Associates LLC - 22 Apr 2024 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 22 Apr 2024
- Net transaction value
- +$481
- SEC form
- 4
- Accepted by SEC
- 24 Apr 2024, 16:30:14 UTC
- Prior SEC filing
- 09 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- Brightstar Associates LLC, By: /s/ Greg A. Hamilton, Member of the Board of Managers
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brightstar Associates LLC filed Form 4 for Deciphera Pharmaceuticals, Inc. on 24 Apr 2024.
Change
- Previous filing in this sequence was filed on 09 Feb 2024.
- Current net transaction value: +$481.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DCPH
transaction
Common Stock
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $481
- Shares
- +48,136
- Change %
- +0.21%
- Price
- $0.0100*
- Shares after
- 23,107,844
- Date
- 22 Apr 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DCPH
transaction
Derivative
Warrants (right to buy)
Exercise of in-the-money or at-the-money derivative security
- Transaction value
- $0
- Shares
- -48,136
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 22 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,136
- Exercise price
- $0.0100
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The warrants have no expiration date.